LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    LanzaTech joins EuropaBio: Recycling Carbon for a Sustainable Future

    15/05/2024

    PRESS RELEASE

    Brussels, 15 May 2024 - EuropaBio, is delighted to announce the addition of LanzaTech as a new Member, joining with a focus on Industrial Biotechnology and Biomanufacturing.

    Founded in 2007, LanzaTech brings solutions for waste conversion through biotechnology. With a mission to drive the transition from a linear fossil-based economy to a circular system, LanzaTech's cutting-edge technology captures industrial process carbon emissions that would otherwise contribute to environmental degradation.

    By harnessing the power of microorganisms, LanzaTech has successfully commercialised the production of ethanol from industrial waste gases, with applications spanning industries including textiles, packaging, detergents, fragrances, and sustainable aviation fuel.

    With their membership and their expertise, LanzaTech will actively engage in policy discussion with EuropaBio to promote biotechnology innovation and sustainability.

    Dr. Claire Skentelbery, Director General of EuropaBio said “Companies such as LanzaTech are a key voice for Europe’s industrial transformation discussion. Its groundbreaking work in carbon capture and biomanufacturing aligns with the EuropaBio goals of fostering a resilient post-fossil Europe.”

    Freya Burton, Chief Sustainability Officer LanzaTech said “Biomanufacturing with carbon capture reduces the need for fossil feedstocks creating more sustainable production pathways for chemicals and related products. We are delighted to have joined EuropaBio that with its members are working to ensure Europe’s innovative biotechnology industry can thrive, creating jobs, economic growth and a healthier planet.”

    LanzaTech joins EuropaBio: Recycling Carbon for a Sustainable Future


    Download
    Share
    Adrian Lincoln
    Adrian Lincoln

    Related posts

    18/05/2026

    Biodefence & Biosecurity in focus for EuropaBio with dedicated Task Force


    Read more
    12/05/2026

    ‘Consistency, cooperation and practicality are the watch words’. EuropaBio reacts to provisional agreement on the Critical Medicines Act


    Read more
    08/05/2026

    Technovative Solutions Ltd. joins EuropaBio: Advancing AI‑Driven and Sustainable Innovation in Biotechnology


    Read more

    Important links

    • Biodefence & Biosecurity in focus for EuropaBio with dedicated Task Force
    • ‘Consistency, cooperation and practicality are the watch words’. EuropaBio reacts to provisional agreement on the Critical Medicines Act

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.